Analysis Cotinga Pharmaceuticals Inc. (COTQF)
6/4/2024
Analysis of Cotinga Pharmaceuticals Inc. (COTQF)
Cotinga Pharmaceuticals Inc. (COTQF) has been trading at a consistent price of 0.00010. The Relative Strength Index (RSI) indicator, Moving Average Convergence Divergence (MACD) indicator, and Moving Averages (MA) indicators are all showing values of 0.00000, indicating a lack of significant price movement or trend.Based on the available data, it appears that Cotinga Pharmaceuticals Inc. has been experiencing a period of price stability with no clear signals of a bullish or bearish trend. Traders and investors may need to wait for more significant price movements or developments to make informed decisions regarding this stock.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released After Hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provides a comprehensive overview of the financial and stock-related metrics for a company. Here are the key points:1. **Financials**:
- **Cash Flow**: Operating cash flow for the trailing twelve months (TTM) is $110,563,000,320. Levered free cash flow TTM is $84,726,874,112.
- **Balance Sheet**: Total cash on a quarterly basis is $67,150,000,128. Total debt on a quarterly basis is $104,590,000,128. Current ratio is 1.037. Book value per share is $4.837. Total cash per share is $4.379. Total debt to equity ratio is 140.968.
- **Profit Margin**: The profit margin is 26.306%.
- **Income Statement**: EBITDA is $131,393,000,000. Revenue TTM is $381,623,009,280. Diluted EPS TTM is $6.43. Gross profit TTM is $169,148,000,000. Revenue per share TTM is $24.537. Net income to common TTM is $100,389,003,264. Quarterly revenue growth is -4.3%. Quarterly earnings growth year-over-year is -2.2%.
- **Operating Margin**: The operating margin is 30.743%.
- **Return on Assets**: Return on assets TTM is 22.073999%.
- **Return on Equity**: Return on equity TTM is 147.25%.
2. **Stock Statistics**:
- **Short Ratio**: 1.53.
- **Float Shares**: 15,308,320,742.
- **Shares Short**: 99,287,450.
- **Average Volume**: 10-day average volume is 46,860,048 and 90-day average volume is 57,498,254.
- **Shares Outstanding**: 15,334,099,968.
- **Percentage Held**: Insiders hold 5.22% and institutions hold 57.589%. Short interest as a percentage of shares outstanding is 0.65%.
3. **Valuations Metrics**:
- **PEG Ratio**: 26.319502.
- **Forward PE**: 26.319502.
- **Trailing PE**: 29.59409.
- **Enterprise Value**: $2,950,762,332,160.
- **Price to Book**: 39.3405.
- **Price to Sales**: 7.646095.
- **Enterprise to EBITDA**: 22.763.
- **Enterprise to Revenue**: 7.732.
- **Market Capitalization**: $2,917,925,650,432.
4. **Stock Price Summary**:
- **Beta**: 1.264.
- **Moving Averages**: 50-day MA is $176.2646 and 200-day MA is $181.0429.
- **52-Week Range**: Low of $164.08 and high of $199.62. Change in the past 52 weeks is 6.853%.
5. **Dividends and Splits**:
- **Payout Ratio**: 14.93%.
- **Dividend Information**: Dividend date is 2024-05-16. Ex-dividend date is 2024-05-10. Last split date was 2020-08-31 with a 4-for-1 split. Forward annual dividend rate is $1. 5-year average dividend yield is 0.73%. Forward annual dividend yield is 0.5255%. Trailing annual dividend rate is $0.97 and trailing annual dividend yield is 0.5097%.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been relatively stable, with gross profit ranging from around $105 billion to $169 billion.
3. Operating income has also shown an increasing trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
4. Net income has been growing consistently, with the company reporting a net income of $57.4 billion in 2020 and $97 billion in 2023.
5. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years, indicating improved profitability.
6. The company has been able to manage its operating expenses effectively, as seen in the growth of net income despite increasing revenues.
7. Overall, the financial performance of the company in terms of revenue and profitability has been positive and shows a healthy growth trajectory.
Cash Flow 💶
Based on the cash flow data provided, we can draw the following conclusions:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 at $111,443,000,000 and the lowest in 2020 at $73,365,000,000.
2. Operating cash flow has generally been increasing over the years, indicating improved operational efficiency and profitability.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
5. Investing activities include the sale and purchase of investments, capital expenditures, and net acquisitions.
6. The end cash position has also been fluctuating, reaching its highest value in 2021 at $35,929,000,000.
7. Stock-based compensation has been a significant component of non-cash items in operating activities.
Overall, the company's cash flow statements reflect a mix of operational, financing, and investing activities that have contributed to its financial performance and liquidity position over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS):1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This is higher than the EPS of $1.35 from the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS estimate is $6.10, with a low estimate of $5.95 and a high estimate of $6.41. This indicates growth from the EPS of $5.67 for the previous year.
4. For the next year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This forecast suggests an increase from the EPS of $6.10 for the current year.
In conclusion, analysts are generally optimistic about the company's future earnings, with expected growth in both quarterly and annual EPS figures.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest that the company has been experiencing strong growth in the past, but analysts expect the growth rate to moderate slightly in the coming years, although it is still expected to be robust compared to the current year's growth rate.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast above the current price. However, there is a wide range of forecasts, from a low of $164 to a high of $275, indicating some uncertainty in the market.
Balance Sheet
These are balance sheets. Here are the conclusions based on the data provided:1. The total assets have been increasing over the years, indicating growth in the company's overall value.
2. Current assets have fluctuated, with some years showing higher cash reserves and others showing higher inventory levels.
3. Non-current assets have generally increased, especially in investments and advances.
4. Total liabilities have also been on the rise, but at a slower pace compared to total assets.
5. Shareholders' equity has shown variations, with retained earnings playing a significant role.
6. The company seems to be investing heavily in non-current assets and long-term debt, possibly for future growth opportunities.
7. Overall, the financial health of the company appears stable, with a good balance between assets, liabilities, and equity.
MACD of COTQF
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
